Quick Answer
Evolent Health, Inc. reported Long-Term Debt of $970.54 million for fiscal year 2025.
Evolent Health, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $970.54M | +97.9% |
| 2024 | $490.52M | -17.8% |
| 2023 | $597.05M | +44.6% |
| 2022 | $412.99M | +91.5% |
| 2021 | $215.68M | -18.1% |
| 2020 | $263.34M | -10.3% |
| 2019 | $293.67M | +32.9% |
| 2018 | $221.04M | +82.1% |
| 2017 | $121.39M | +0.9% |
| 2016 | $120.28M | — |
| 2015 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.05B | +75.9% | +62.7% |
| June 30, 2025 | $648.46M | +8.3% | +0.1% |
| March 31, 2025 | $647.53M | +8.3% | +32.0% |
| December 31, 2024 | $490.52M | -17.8% | -18.2% |
| September 30, 2024 | $599.67M | -0.0% | +0.1% |
| June 30, 2024 | $598.78M | -5.4% | +0.1% |
| March 31, 2024 | $597.90M | -5.4% | +0.1% |
| December 31, 2023 | $597.05M | +44.6% | -0.5% |
- Evolent Health, Inc. showed an increase of +97.9% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from Evolent Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: